Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Food Allergy Biotech Acquired for $2.6B

Palforzia capsules

Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion. . . . → Read More: Food Allergy Biotech Acquired for $2.6B

Covid-19 Vaccines, Therapies – 31 August 2020

Covid-19 vaccine and therapy tracker

The European Commission announced today a contribution of €400 million ($US 477 million) to the COVID-19 Vaccine Global Access, or Covax, consortium. . . . → Read More: Covid-19 Vaccines, Therapies – 31 August 2020

Does Ad Tech Explain The Recession Recovery?

Technology seems to be allowing the factors of production to slosh about at will, without much friction. . . . → Read More: Does Ad Tech Explain The Recession Recovery?

Taking a Break

Photographer

We’re taking this week off at Science & Enterprise, to concentrate on a big photography project, and will return on 31 August. . . . → Read More: Taking a Break

Infographic – Biotech Index Cruising in High Range

NBI, Feb - Aug 2020

Looking back to May shows that NBI has largely settled in to the 4,000 to 4,500 range, without volatile swings in either direction. . . . → Read More: Infographic – Biotech Index Cruising in High Range

Engineered Mosquitoes Approved for Disease Control

Aedes aegypti mosquito

In an apparent end to a long-running dispute, authorities in the Florida Keys approved a field trial of engineered mosquitoes to control tropical diseases. . . . → Read More: Engineered Mosquitoes Approved for Disease Control

Space Mission Testing Sail to Return Launch Vehicles

Drag sail time lapse

A space mission in November will test a device that works like a sail to bring back launch vehicles faster, designed by university aerospace lab and start-up company. . . . → Read More: Space Mission Testing Sail to Return Launch Vehicles

DoD Funding Variable Covid-19 Vaccine Technology

SARS-Cov-2 virus

The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus. . . . → Read More: DoD Funding Variable Covid-19 Vaccine Technology

Vaccine Blocks Covid-19 Infections in Animal Tests

Syringe

An experimental vaccine shows in challenge tests with monkeys it protects against Covid-19 infections in nose, throat, and airways. . . . → Read More: Vaccine Blocks Covid-19 Infections in Animal Tests

Do The Economics Of Online Retail Make Sense?

Commentators that have done in-depth analyses on the likely future performance of the sector also seem to agree that things will get better. . . . → Read More: Do The Economics Of Online Retail Make Sense?